Delivery Order SPE2DR25D1053-SPE2DR26FW018
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $33,612.29 to AmerisourceBergen Drug Corp on February 3, 2026, for the supply of RINVOQ ER 15 mg tablets (30-count units). This competitively awarded, firm fixed-price contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 4, 2026. The award carries no set-aside designation, indicating full and open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,558.42 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of RINVOQ ER 15mg tablets (30-count supply). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $13.5 million to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on January 20, 2026, with completion scheduled for January 21, 2026. This firm fixed-price contract, which carries no set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $96,055.75 to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of RINVOQ ER 45 mg tablets (28-tablet units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 30, 2026. The vendor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's parent...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for RINVOQ ER 15 mg tablets in a quantity of 30 units, with a ceiling value of $17,417.68. This firm fixed-price delivery order, which has no set-aside designation, is set to be completed by December 9, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a pharmaceutical product used in the treatment of inflammatory conditions,...
- The Defense Logistics Agency awarded a $21,471.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of RINVOQ ER 30 mg tablets (30-count units), with a completion date of January 21, 2026. This non-set-aside delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $35,548.15 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on January 20, 2026, with an ultimate completion date of January 21, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $35.9K firm fixed-price delivery order to AmerisourceBergen Drug Corp on February 2, 2026, for the supply of RINVOQ ER 30 mg tablets in quantities of 30-unit packages. This delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99M through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply distribution to military...
- The Defense Logistics Agency awarded a delivery order valued at $16,270.47 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract requires delivery to Conshohocken, Pennsylvania, where the awardee maintains its corporate office. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open...
- The Defense Logistics Agency awarded a delivery order valued at $6,762.36 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single task order under AmerisourceBergen's larger...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FW018Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,076.40 to AmerisourceBergen Drug Corp on February 3, 2026, for the supply of RINVOQ ER 30 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order will be fulfilled at the company's Conshohocken, Pennsylvania location and is scheduled for completion by February 4, 2026. The contract carries no set-aside designation, indicating open competition among qualified vendors. This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The current order for RINVOQ ER, a pharmaceutical treatment, exemplifies the ongoing fulfillment of critical medical supply needs for federal military and healthcare systems through this established contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 2/2/26 |